Results: 1-18 |

Table of contents of journal:

Results: 18

Authors: Carratala, J Gudiol, F
Citation: J. Carratala et F. Gudiol, Changing epidemiology of bacterial infection in neutropenic patients with cancer, ANTIB CHEMY, 50, 2000, pp. 1-9

Authors: Sudhoff, T Giagounidis, A Karthaus, M
Citation: T. Sudhoff et al., Serum and plasma parameters in clinical evaluation of neutropenic fever, ANTIB CHEMY, 50, 2000, pp. 10-19

Authors: Egerer, G Karthaus, M Goldschmidt, H Ho, AD
Citation: G. Egerer et al., Antimicrobial therapy in neutropenic patients, ANTIB CHEMY, 50, 2000, pp. 20-25

Authors: Karthaus, M Sudhoff, T Egerer, G Fenchel, K Kampfe, D Ritter, J Franke, A Heil, G Peters, G Jurgens, H
Citation: M. Karthaus et al., Interventional once-daily administration of ceftriaxone in leukemia and lymphoma patients with febrile neutropenia, ANTIB CHEMY, 50, 2000, pp. 26-36

Authors: Cornely, OA Salzberger, B Bethe, U Seifert, H Fatkenheuer, G Diehl, V Schrappe, M
Citation: Oa. Cornely et al., Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever, ANTIB CHEMY, 50, 2000, pp. 37-46

Authors: Karthaus, M Egerer, G Jurgens, H
Citation: M. Karthaus et al., Outpatient treatment of cancer patients with fever and neutropenia, ANTIB CHEMY, 50, 2000, pp. 47-58

Authors: Buchheidt, D Skladny, H Baust, C Hehlmann, R
Citation: D. Buchheidt et al., Current serological and molecular methods in the diagnosis of systemic infections with Candida sp and Aspergillus sp in immunocompromised patients with hematological malignancies, ANTIB CHEMY, 50, 2000, pp. 59-68

Authors: Bohme, A Karthaus, M Hoelzer, D
Citation: A. Bohme et al., Antifungal prophylaxis in neutropenic patients with hematologic malignancies, ANTIB CHEMY, 50, 2000, pp. 69-78

Authors: Bohme, A Karthaus, M
Citation: A. Bohme et M. Karthaus, Treatment of systemic fungal infections in patients with hematologic malignancies, ANTIB CHEMY, 50, 2000, pp. 79-93

Authors: Seipelt, G
Citation: G. Seipelt, Clinical use of hematopoietic growth factors, ANTIB CHEMY, 50, 2000, pp. 94-105

Authors: Stilgenbauer, F Egerer, G Karthaus, M Goldschmidt, H Ho, AD
Citation: F. Stilgenbauer et al., Recombinant human erythropoietin in the treatment of cancer, ANTIB CHEMY, 50, 2000, pp. 106-114

Authors: Rosenthal, C Karthaus, M Ganser, A
Citation: C. Rosenthal et al., New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis, ANTIB CHEMY, 50, 2000, pp. 115-132

Authors: Salwender, HJ Egerer, G Bach, A Hahn, U Goldschmidt, H Ho, AD
Citation: Hj. Salwender et al., Central venous catheter-related complications, ANTIB CHEMY, 50, 2000, pp. 133-143

Authors: Fenchel, K Karthaus, M
Citation: K. Fenchel et M. Karthaus, Cytotoxic drug extravasation, ANTIB CHEMY, 50, 2000, pp. 144-148

Authors: Prondzinski, MV Karthaus, M Ganser, A Barthels, M
Citation: Mv. Prondzinski et al., Anticoagulant prophylaxis and therapy in patients with cancer, ANTIB CHEMY, 50, 2000, pp. 149-158

Authors: Meran, JG Karthaus, M Ludwig, H
Citation: Jg. Meran et al., Quality of life assessment - Problems and goals, ANTIB CHEMY, 50, 2000, pp. 159-170

Authors: Egerer, G Hegenbart, U Salwender, HJ Goldschmidt, H Ho, AD
Citation: G. Egerer et al., Treatment of chemotherapy-induced emesis, ANTIB CHEMY, 50, 2000, pp. 171-183

Authors: Hartmann, JT Bokemeyer, C
Citation: Jt. Hartmann et C. Bokemeyer, Diarrhea and constipation, ANTIB CHEMY, 50, 2000, pp. 184-188
Risultati: 1-18 |